AI assistant
Sending…
SUPERNUS PHARMACEUTICALS, INC. — Director's Dealing 2012
May 7, 2012
31512_dirs_2012-05-07_3b9f30b8-1773-4051-a0b1-315710ed43fc.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SUPERNUS PHARMACEUTICALS INC (SUPN)
CIK: 0001356576
Period of Report: 2012-05-04
Reporting Person: PATRICK GREGORY S (VP, Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-05-04 | Common Stock | P | 3000 | $5.00 | Acquired | 3000 | Direct |
More from SUPERNUS PHARMACEUTICALS, INC.
Capital/Financing Update
2026
Jun 22
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 18
Call Transcript
2026
Jun 3
Regulatory Filings
2026
May 20
Call Transcript
2026
May 13
Call Transcript
2026
May 5
Regulatory Filings
2026
Apr 22
Capital/Financing Update
2026
Apr 7
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 18